NCT00386997View on ClinicalTrials.gov

ProphyALL - Study on the Safety of Liposomal Amphotericin B to Prevent Antifungal Infections in Elderly Patients With Acute Lymphoblastic Leukemia

PHASE4TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2006

Study Completion Date

September 30, 2007

Conditions
Fungal Infection
Interventions
DRUG

liposomal amphotericin B (AmBisome®)

Trial Locations (1)

82152

Gilead Sciences GmbH, Martinsried/Munich

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY